Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

The new assay can help develop products for hair re-growth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

A new treatment for hair loss shows promise with fewer side effects.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

SARMs work differently in tissues due to unique interactions and structures.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.